Adapthealth CORP 8-K filings

AdaptHealth Corp. announced its second quarter 2026 financial results, reporting a net loss and lowering its full-year outlook, while also detailing the divestiture of its Diabetes Health business.

AdaptHealth Corp. has entered into a definitive agreement to divest its Diabetes Health business to Cardinal Health for $235 million in cash.

AdaptHealth Corp. has disclosed a material cybersecurity incident involving unauthorized access to its systems and exfiltration of patient data, including passwords for insurance billing.

AdaptHealth Corp. announced its first quarter 2026 financial results, highlighting a significant de novo expansion and a $1.1 billion refinancing, alongside the departure of its Chief Operating Officer.

AdaptHealth Corp. has closed a $1.1 billion senior secured credit facility, extending its debt maturity and reducing borrowing costs.

AdaptHealth Corp. announced its fourth quarter and full-year 2025 financial results, including a net loss, alongside positive operational growth and robust 2026 financial guidance.

AdaptHealth Corp. announced strong third-quarter 2025 financial results, surpassing expectations with increased revenue and significant debt reduction, while maintaining its full-year guidance.

AdaptHealth reports a slight revenue decrease and lower Adjusted EBITDA for Q2 2025, alongside progress in debt reduction and new strategic partnerships.

AdaptHealth Corp. announced a definitive 5-year agreement to be the exclusive home medical equipment provider for a major national healthcare system covering over 10 million members.

AdaptHealth Corp. announced the closing of its infusion asset disposition, leading to significant debt reduction and a revision of its full-year 2025 financial guidance.

AdaptHealth Corp. announced that its stockholders approved all three proposals at the annual meeting held on June 18, 2025, including the election of six directors, the ratification of KPMG LLP as its independent auditor, and the advisory approval of executive compensation.

AdaptHealth Corp. reports a decrease in net revenue and adjusted EBITDA for Q1 2025, while updating its financial guidance for the year following asset dispositions.

AdaptHealth Corp. reports its financial results for Q4 and the full year 2024, showing increased full-year revenue and provides its financial outlook for 2025.

AdaptHealth Corp. has amended its separation agreement with Chief Business Officer Shaw Rietkerk, reducing his annual base salary to $125,000 from January 1, 2025, until his separation date.

AdaptHealth Corp. reports a profitable third quarter with increased revenue and adjusted EBITDA, while also updating its full-year financial guidance.

AdaptHealth Corp. has entered into a new employment agreement with its Chief Technology Officer, Albert Prast, effective October 30, 2024, superseding his previous agreement.

AdaptHealth Corp. has appointed Diana Nole to its Board of Directors, effective October 16, 2024, bringing her extensive healthcare technology leadership experience to the company.

AdaptHealth Corp. has issued a notice correcting the expiration date of its private placement warrants to November 8, 2024, from a previously misreported date of November 20, 2024.

AdaptHealth Corp. has successfully refinanced its senior secured credit facility, resulting in an extended maturity date to September 2029 and reduced interest rate pricing.

AdaptHealth Corp. has announced the appointment of Toby Scott Barnhart as its new Chief Operating Officer, effective September 23, 2024.

AdaptHealth Corp. is transitioning its Chief Operating Officer, Shaw Rietkerk, to a new role as Chief Business Officer by the end of September 2024.

AdaptHealth Corp. reported a 1.6% increase in net revenue and a 39% increase in net income for the second quarter of 2024, while updating its full-year financial guidance.

AdaptHealth Corp. announced the resignation of its President, Joshua Parnes, effective August 31, 2024, and the appointment of Dale Wolf as the new Chair of the Board, effective July 1, 2024.

AdaptHealth Corp. stockholders approved an increase in shares reserved under the stock incentive plan and a phase-out of the classified board structure at their annual meeting on June 20, 2024.

AdaptHealth Corp. announced a 6.4% increase in net revenue for Q1 2024, but experienced a net loss due to the impact of the Change Healthcare data breach.

AdaptHealth Corp. has appointed Suzanne Foster as its new Chief Executive Officer, effective May 20, 2024, succeeding interim CEO Richard Barasch.

AdaptHealth Corp. has extended the term of its Interim CEO, Richard Barasch, to April 30, 2024, and granted him additional restricted stock units.

AdaptHealth Corp. announced a 7.7% increase in full-year revenue and a 40.2% increase in Q4 adjusted EBITDA, despite a significant goodwill write-down impacting net income.